Advertisements



Gilead Analysts React To Failed NASH Trial: Citigroup, Wells Fargo Downgrade Biotech

One of the three widely awaited clinical trial readouts from Gilead Sciences, Inc. (NASDAQ: GILD) turned out to be a disappointment, sending its shares down sharply Tuesday.  Latest Ratings for GILD.....»»

Category: blogSource: benzingaFeb 12th, 2019

Dash for NASH trips up Gilead, but "fatty liver disease" remains biotech target

A late-stage clinical trial by Gilead Sciences Inc. failed in fatty liver disease, the company said, sending a blow to a drug industry that has seen treatments for the disease as the next big thing. The Foster City-based company's (NASDAQ: GILD) s.....»»

Category: topSource: bizjournalsFeb 12th, 2019

Intercept Pharmaceuticals is one step closer to getting FDA approval for the first-ever NASH drug

Intercept Pharmaceuticals Inc. announced Tuesday that a potential therapy for the fatty liver disease known as NASH had achieved its primary goal in a Phase 3 trial, a week after Gilead Sciences Inc. announced a competing trial had failed......»»

Category: topSource: marketwatchFeb 19th, 2019

"A Negative Inflection": Wells Fargo, Morgan Stanley React To NetApp"s Q3 Sales Miss, Weak Guidance

NetApp Inc. (NASDAQ: NTAP) shares were under pressure Thursday in reaction to third-quarter results released Wednesday after the market close that included a sales miss.  The Analysts.....»»

Category: earningsSource: benzingaFeb 14th, 2019

Gilead"s Failed NASH Drug Trial Drags Stock Lower

Gilead Sciences, Inc. (NASDAQ: GILD) is facing another setback, as its non-alcoholic steatohepatitis, or NASH, candidate Selonsertib flunked in a late-stage study. read more.....»»

Category: blogSource: benzingaFeb 12th, 2019

Aeglea Plunges On Updated Data For Arginase 1 Deficiency Candidate, Wells Fargo Downgrade

Shares of Aeglea Bio Therapeutics Inc (NASDAQ: AGLE) were slumping Tuesday following the release of data from an early-to-mid- stage trial of its lead product c read more.....»»

Category: blogSource: benzingaSep 4th, 2018

AT&T suffers downgrade as analysts see "many balls to juggle" with Time Warner

AT&T might have the right plan with Time Warner and fresh video options, but a new analyst note says it’s going to take a lot to navigate that journey. Analysts at Wells Fargo downgraded shares of AT&T (NYSE: T) on Wednesday amid concerns about.....»»

Category: topSource: bizjournalsAug 23rd, 2018

Q1 Earnings Continue

More Wall Street banks reported earnings this morning following Friday morning s kick off with 160 JPMorgan 160 JPM 160 and 160 Wells Fargo 160 WFC 160 Citigroup 160 C 160 and 160 Goldman Sachs 160 GS both Zacks Rank 4 Sell rated companies ahead of their.....»»

Category: economySource: nasdaqApr 16th, 2019

Analysts See Well Fargo (NYSE:WFC) as ‘Dead Money’

$WFC Wells Fargo & Co. (NYSE:WFC) shares are extending Friday’s declines in Monday pre-market trading, as analyst downgrades pile on after the bank lowered its net interest income forecast. Firms cutting their rati.....»»

Category: topSource: livetradingnewsApr 16th, 2019

Kate Spade could have another tough earnings period but a new designer can turn things around

Wells Fargo analysts are forecasting another tough quarterly report from Tapestry Inc. brand Kate Spade, but say the brand's new designer, Nicola G.....»»

Category: topSource: marketwatchApr 16th, 2019

JPMorgan, Wells Fargo Issue Mixed Q1 Reports; Analysts Weigh In

Shares of big U.S. Latest Ratings for .....»»

Category: blogSource: benzingaApr 15th, 2019

JPMorgan, Wells Fargo Issue Mixed Q1 Reports; Analysts Weigh In

Shares of big U.S. banks Wells Fargo & Co (NYSE: WFC) and JPMorgan Chase & Co. (NYSE: JPM) headed in different directions Friday after the banks reported mixed first-quarter earnings. We.....»»

Category: earningsSource: benzingaApr 15th, 2019

Wells Fargo beats analysts" predictions in first-quarter earnings report

Wells Fargo & Co. (NYSE: WFC) beat analysts' predictions in its first-quarter earnings report released this morning. The San Francisco-based bank posted net income of $5.9 billion, or $1.20 in diluted earnings per share. First-quarter revenue came to $.....»»

Category: topSource: bizjournalsApr 12th, 2019

Wells Fargo medtech analysts to hold an analyst/industry conference call

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 12th, 2019

Challenges Stack Up For Big Banks: Earnings Ahead For JPMorgan, Wells Fargo, Citigroup

Challenges Stack Up For Big Banks: Earnings Ahead For JPMorgan, Wells Fargo, Citigroup.....»»

Category: topSource: seekingalphaApr 11th, 2019

Challenges Stack Up As JP Morgan, Wells Fargo, Citigroup Prepare To Report

Lower trading volume. Falling mortgage rates. An inverted Treasury yield curve. A slowing U.S. and global economy. The odds seem pretty stacked against big banks on multiple fronts as earnings season starts tomorrow. Making .....»»

Category: personnelSource: nytApr 11th, 2019

The Daily Biotech Pulse: NASH Cheer For Intercept, Gilead Layoffs, BioDelivery Licenses Constipation Drug

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on April 10) read more.....»»

Category: blogSource: benzingaApr 11th, 2019

Intel stock falls after Wells Fargo downgrade

Shares of Intel Corp. are down 0.9% in premarket trading Friday after Wells Fargo analyst Aaron Rakers cut his rating on the stock to market perform from outperform. "Weak semi demand data points thus far in 2019, coupled with an expectation of.....»»

Category: topSource: marketwatchApr 5th, 2019

Outsider CEO won"t be a quick fix for Wells Fargo: analysts

Wells Fargo & Co's plan to bring in an outsider as its next chief executive could give the scandal-plagued bank a much needed fresh start, but a turnaround will not be easy for whoever takes the helm, analysts said......»»

Category: topSource: reutersMar 29th, 2019

Outsider CEO won"t be an instant fix for Wells Fargo: analysts

Wells Fargo & Co's plans to bring in an outsider as its next chief executive could give the scandal-plagued bank a much needed fresh start, but a turnaround will not be easy for whoever takes the helm, analysts said......»»

Category: topSource: reutersMar 29th, 2019

Analysts call Wells Fargo CEO exit "positive," though "not without challenges"

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 29th, 2019